Different-dose docetaxel plus cisplatin as first-line chemotherapy and then maintenance therapy with single-agent docetaxel for advanced non-small cell lung cancer (TFINE study, C-TONG 0904).

Authors

Li Zhang

Li Zhang

Sun Yat-sen University Cancer Center, Guangzhou, China

Li Zhang , Shun Lu , Ying Cheng , Zhihuang Hu , Zhiwei Chen , Gongyan Chen , Xiaoqing Liu , Jinji Yang , Li Zhang , Jia Chen , Meijuan Huang , Min Tao , Gang Cheng , Cheng Huang , Caicun Zhou , Weimin Zhang , Hong Zhao

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Lung Cancer - Non-small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT01038661

Citation

J Clin Oncol 31, 2013 (suppl; abstr 8015)

DOI

10.1200/jco.2013.31.15_suppl.8015

Abstract #

8015

Poster Bd #

4

Abstract Disclosures